A Real-World Analysis of the Clinical Journey, Diagnosis, and Monitoring Patterns of Patients With Alzheimer Disease by Stage in the United States
This is my archive
The impact of real-world evidence in implementing and optimizing Alzheimer’s disease care
Measuring time saved in Alzheimer’s disease: What is a meaningful slowing of progression?
Real-world diagnostic, referral, and treatment patterns in early Alzheimer’s disease among community-based practices in the United States
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis
Projected Ontario budget savings from reduced long-term care utilization due to a disease-modifying Alzheimer’s treatment
Association of Adverse Events in Opioid Addiction Treatment With Quality Measure for Continuity of Pharmacotherapy
Estimating minimal clinically important differences for two scales in patients with chronic traumatic brain injury
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia
Evidence for Misspecification of a Nationally Used Quality Measure for Substance Use Treatment
